TMCI vs. SIBN, ATRI, EMBC, SILK, IRMD, KIDS, OFIX, FNA, SRDX, and OSUR
Should you be buying Treace Medical Concepts stock or one of its competitors? The main competitors of Treace Medical Concepts include SI-BONE (SIBN), Atrion (ATRI), Embecta (EMBC), Silk Road Medical (SILK), Iradimed (IRMD), OrthoPediatrics (KIDS), Orthofix Medical (OFIX), Paragon 28 (FNA), Surmodics (SRDX), and OraSure Technologies (OSUR). These companies are all part of the "surgical & medical instruments" industry.
Treace Medical Concepts (NASDAQ:TMCI) and SI-BONE (NASDAQ:SIBN) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and community ranking.
SI-BONE received 136 more outperform votes than Treace Medical Concepts when rated by MarketBeat users. Likewise, 67.23% of users gave SI-BONE an outperform vote while only 54.55% of users gave Treace Medical Concepts an outperform vote.
Treace Medical Concepts has a net margin of -27.93% compared to SI-BONE's net margin of -29.93%. SI-BONE's return on equity of -25.14% beat Treace Medical Concepts' return on equity.
Treace Medical Concepts has a beta of 0.37, indicating that its stock price is 63% less volatile than the S&P 500. Comparatively, SI-BONE has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500.
84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 98.1% of SI-BONE shares are owned by institutional investors. 24.4% of Treace Medical Concepts shares are owned by company insiders. Comparatively, 5.4% of SI-BONE shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
In the previous week, Treace Medical Concepts had 5 more articles in the media than SI-BONE. MarketBeat recorded 30 mentions for Treace Medical Concepts and 25 mentions for SI-BONE. SI-BONE's average media sentiment score of 0.45 beat Treace Medical Concepts' score of -0.31 indicating that SI-BONE is being referred to more favorably in the news media.
SI-BONE has lower revenue, but higher earnings than Treace Medical Concepts. SI-BONE is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.
Treace Medical Concepts currently has a consensus price target of $13.57, suggesting a potential upside of 209.85%. SI-BONE has a consensus price target of $27.29, suggesting a potential upside of 77.99%. Given Treace Medical Concepts' higher possible upside, equities research analysts plainly believe Treace Medical Concepts is more favorable than SI-BONE.
Summary
SI-BONE beats Treace Medical Concepts on 11 of the 18 factors compared between the two stocks.
Get Treace Medical Concepts News Delivered to You Automatically
Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Treace Medical Concepts Competitors List
Related Companies and Tools
